Choksi Laboratories Limited (BOM:526546)
India · Delayed Price · Currency is INR 122.95
-5.05 (-3.95%)
At close: Jun 19, 2026
Choksi Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 19.64 | 15.23 | 11.1 | 32.1 | 2.07 |
Depreciation & Amortization | 70.89 | 63.69 | 57.14 | 54.98 | 54.28 |
Other Amortization | - | 1.3 | - | - | - |
Loss (Gain) From Sale of Assets | -7.42 | 0 | 0.05 | 0.01 | -0.04 |
Provision & Write-off of Bad Debts | 5.39 | 3.43 | 2.23 | 3.7 | 2.07 |
Other Operating Activities | 33.85 | 12.24 | 29.01 | 22.87 | 44.24 |
Change in Accounts Receivable | -39.95 | -12.23 | 0.38 | -7.33 | -23.38 |
Change in Inventory | 3.2 | -1.93 | -1.55 | 0.41 | -1.38 |
Change in Accounts Payable | 1.76 | 14.95 | 21.32 | -22.16 | -8.15 |
Change in Other Net Operating Assets | -8.72 | 21.11 | -4.16 | -2.04 | 9.06 |
Operating Cash Flow | 78.65 | 117.78 | 115.52 | 82.54 | 78.77 |
Operating Cash Flow Growth | -33.23% | 1.96% | 39.95% | 4.78% | 33.55% |
Capital Expenditures | -79.77 | -74.39 | -70.05 | -39.53 | -26.8 |
Sale of Property, Plant & Equipment | 9.27 | 0.02 | 0.9 | 32.4 | 0.38 |
Sale (Purchase) of Intangibles | -1.99 | -2.48 | -0.9 | -1.98 | -1.83 |
Investment in Securities | - | 0.2 | 1.93 | 0.05 | - |
Other Investing Activities | 1.75 | 0.6 | 1.64 | 1.97 | 1.16 |
Investing Cash Flow | -70.75 | -76.05 | -66.48 | -7.08 | -27.09 |
Short-Term Debt Issued | - | 9.85 | 42.47 | - | 0.13 |
Long-Term Debt Issued | 89.09 | 38.39 | 310.1 | 20.04 | 26.71 |
Total Debt Issued | 89.09 | 48.24 | 352.57 | 20.04 | 26.84 |
Short-Term Debt Repaid | -5.03 | - | - | -8.98 | - |
Long-Term Debt Repaid | -67.85 | -63.92 | -368.35 | -59.78 | -45.42 |
Total Debt Repaid | -72.88 | -63.92 | -368.35 | -68.77 | -45.42 |
Net Debt Issued (Repaid) | 16.21 | -15.68 | -15.78 | -48.73 | -18.59 |
Other Financing Activities | -28.16 | -26.49 | -30.05 | -27.42 | -32.09 |
Financing Cash Flow | -11.96 | -42.18 | -45.84 | -76.15 | -50.68 |
Miscellaneous Cash Flow Adjustments | - | 0 | - | -0 | - |
Net Cash Flow | -4.06 | -0.45 | 3.19 | -0.7 | 1.01 |
Free Cash Flow | -1.13 | 43.39 | 45.47 | 43.01 | 51.98 |
Free Cash Flow Growth | - | -4.58% | 5.72% | -17.26% | - |
Free Cash Flow Margin | -0.24% | 10.38% | 12.39% | 12.49% | 17.30% |
Free Cash Flow Per Share | -0.16 | 6.23 | 6.53 | 6.17 | 7.46 |
Cash Interest Paid | 28.16 | 26.49 | 30.05 | 34.92 | 32.09 |
Cash Income Tax Paid | 4.86 | 19.96 | 4.93 | -7.44 | -11.72 |
Levered Free Cash Flow | -32.44 | 19.43 | 7.35 | -1.34 | 12.6 |
Unlevered Free Cash Flow | -14.84 | 36.05 | 26.15 | 20.5 | 32.68 |
Change in Working Capital | -43.71 | 21.89 | 15.99 | -31.12 | -23.86 |